Questions about COVID-19?

What Patients & Families Need to Know | New Visitor PolicyGuidance for Community Healthcare Providers

A photo of Anne Lucky.

Medical Director, Epidermolysis Bullosa Center

Volunteer Professor of Dermatology and Pediatrics, UC Department of Pediatrics



Board Certified

Best Doctors logo

About Me


Dr. Anne Lucky is a pediatric dermatologist who is currently working at both Cincinnati Children’s and in private practice. She obtained her medical degree from the Yale University School of Medicine. She has a long academic career in laboratory and clinical practice with over 200 peer-reviewed publications, as well as many reviews, book chapters, and national and international invited lectures.

She is the director of the Epidermolysis Bullosa Center and a founding member of the Hemangioma and Vascular Malformation Center. She holds board certification in pediatric dermatology, pediatrics, pediatric endocrinology and dermatology and has served as the president of the Society for Pediatric Dermatology and the American Board of Dermatology. She is active in the Hemangioma Investigator Group (HIG) which a multi-institutional research consortium to provide quality data on the safety and effectiveness of the novel application of therapeutics in infantile hemangiomas. Dr. Lucky’s specialties include all aspects of pediatric dermatology.

Clinical Interests

All aspects of pediatric dermatology, especially acne

Academic Affiliation

Volunteer Professor of Dermatology and Pediatrics, UC Department of Pediatrics


Dermatology, Hemangioma and Vascular Malformations, Epidermolysis Bullosa EB

My Locations

My Education

BA: Pembroke College in Brown University, Providence, RI, 1966.

MD: Yale University School of Medicine, New Haven, CT, 1970.

Residency: Children's Hospital Medical Center, Boston, MA, 1973; Yale University School of Medicine, New Haven, CT, 1981.

Fellowship: Human Genetics and Pediatrics, Yale University School of Medicine, New Haven, CT, 1974; Clinical Associate (Endocrinology), Reproduction Research Branch of the National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Md., 1976.

Certification: Pediatrics, 1975; Pediatric Endocrinology, 1978; Dermatology, 1981.

My Publications

Collagen VII Expression is Required in Both Keratinocytes and Fibroblasts for Anchoring Fibril Formation in Bilayer Engineered Skin Substitutes. Supp, DM; Hahn, JM; Combs, KA; McFarland, KL; Schwentker, A; Boissy, RE; Boyce, ST; Powell, HM; Lucky, AW. Cell Transplantation. 2019; 28:1242-1256.

Persistent linear pruritic papules on the hands of a teenage girl. Shaughnessy, CN; Lucky, AW. Pediatric Dermatology. 2019; 36:E81-E82.

Assessment of the Timing of Milestone Clinical Events in Patients With Epidermolysis Bullosa From North America. Feinstein, JA; Jambal, P; Peoples, K; Lucky, AW; Khuu, P; Tang, JY; Lara-Corrales, I; Pope, E; Wiss, K; Hook, KP; et al. JAMA Dermatology. 2019; 155:196-203.

Epidermolysis bullosa simplex-generalized severe type due to keratin 5 p.Glu477Lys mutation: Genotype-phenotype correlation and in silico modeling analysis. Lalor, L; Titeux, M; Palisson, F; Fuentes, I; Yubero, MJ; Tasanen, K; Huilaja, L; Has, C; Tadini, G; Haggstrom, AN; et al. Pediatric Dermatology. 2019; 36:132-138.

Clinical algorithm to manage anemia in epidermolysis bullosa. Simpson, B; Tarango, C; Lucky, AW. Pediatric Dermatology. 2018; 35:e319-e320.

Pediatric Ophthalmoplegia and Ptosis in Epidermolysis Bullosa Simplex Associated With Muscular Dystrophy. Al-Thawabieh, W; Lucky, AW; Wong, B; Motley, WW. Journal of Pediatric Ophthalmology and Strabismus. 2018; 55:e26-e29.

Reliability and validity of the instrument for scoring clinical outcomes of research for epidermolysis bullosa (iscorEB). Bruckner, AL; Fairclough, DL; Feinstein, JA; Lara-Corrales, I; Lucky, AW; Tolar, J; Pope, E. British Journal of Dermatology. 2018; 178:1128-1134.

A comprehensive next-generation sequencing assay for the diagnosis of epidermolysis bullosa. Lucky, AW; Dagaonkar, N; Lammers, K; Husami, A; Kissell, D; Zhang, K. Pediatric Dermatology. 2018; 35:188-197.

Ventricular dysfunction and aortic dilation in patients with recessive dystrophic epidermolysis bullosa. Ryan, TD; Lucky, AW; King, EC; Huang, G; Towbin, JA; Jefferies, JL. British Journal of Dermatology. 2016; 174:671-673.

Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies. Adams, DM; III, TC C; Hammill, AM; Vinks, AA; Patel, MN; Chaudry, G; Wentzel, MS; Mobberley-Schuman, PS; Campbell, LM; Brookbank, C; et al. Pediatrics. 2016; 137:e20153257-e20153257.